1-11 of 11
Jennifer JD Morrissette
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Drivers of Clonal Hematopoiesis Shape the Subsequent Evolutionary Trajectories of De Novo AML

Ryan D Chow, Priya Velu, Safoora Deihimi, Jonathan Belman, Angela Youn, Nisargbhai Shah, Jennifer JD Morrissette, Robert L. Bowman
Journal: Blood
Blood (2024) 144 (Supplement 1): 1536.
https://doi.org/10.1182/blood-2024-206642
Published: 2024
Journal Articles

Title: Development of a Pathologic Prognostic Index (PPI) for Newly Diagnosed Large B Cell Lymphoma Patients Treated with R-CHOP

Vincent Ni, Sunita D. Nasta, Stefan K. Barta, Stephen J. Schuster, Elise A. Chong, Jakub Svoboda, Jennifer JD Morrissette, Ashley Barlev, Adam Bagg, Salvatore F. Priore, Daniel J. Landsburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 3083.
https://doi.org/10.1182/blood-2024-203448
Published: 2024
Journal Articles

DNA Damage Response Constrains Cell Growth and Drives Clonal Hematopoiesis in Telomere Biology Disorders

Christopher M Sande, Stone Chen, Dana V Mitchell, Ping Lin, Rujul Jagdish Deolikar, Colby Freeman, Mary Zhou, Sushant Kumar, Shannon Zheng, Bolormaa Munkhbileg, Natasha L Stanley, Kathy Guo, Ryan Hausler, Deanne M Taylor, James Corines, Jennifer JD Morrissette, David B Lieberman, Guang Yang, Kelcy Smith-Simmer, Lauren G Banaszak, Kyle Shoger, Peter Nicholas, Amanda J Walne, Inderjeet Dokal, Justin Rosenheck, Jane E Churpek, F Bradley Johnson, Timothy S Olson, Daria V Babushok
Journal: Blood
Blood (2023) 142 (Supplement 1): 1356.
https://doi.org/10.1182/blood-2023-173666
Published: 2023
Journal Articles

TP53 Mutations Detected By Clinical Laboratory Mutation Analysis Predict for Inferior Clinical Outcomes in Patients with Newly-Diagnosed Aggressive B Cell Lymphomas, Including Those with High-Risk Features

Daniel J. Landsburg, Jennifer JD Morrissette, Sunita D. Nasta, Stefan K. Barta, Stephen J Schuster, Jakub Svoboda, Elise A. Chong, Adam Bagg
Journal: Blood
Blood (2023) 142 (Supplement 1): 1739.
https://doi.org/10.1182/blood-2023-186343
Published: 2023
Journal Articles

Impact of Genetic Mutations on Survival Following Receipt of Commercial CART19 for Patients Diagnosed with Aggressive B Cell Lymphoma

Benjamin Frost, Jennifer JD Morrissette, Stephen J Schuster, Sunita D. Nasta, Jakub Svoboda, Stefan K. Barta, Elise A. Chong, Marco Ruella, Adam Bagg, Daniel J. Landsburg
Journal: Blood
Blood (2023) 142 (Supplement 1): 3518.
https://doi.org/10.1182/blood-2023-186553
Published: 2023
Journal Articles

Somatic Mutation Screening in Adult Patients with Myeloid Malignancies Provides Insights into Likely Germline Variants

Rahul S. Bhansali, Xin Wang, Valentina Mattfeld, Dana F. Clark, Jennifer JD Morrissette, Martin Carroll, Daria Babushok, Ximena Jordan Bruno
Journal: Blood
Blood (2023) 142 (Supplement 1): 5665.
https://doi.org/10.1182/blood-2023-174488
Published: 2023
Journal Articles

Next Generation Sequencing (NGS) Identifies an Association Between NPM1 Mutation and Leukemia Cutis

Marlise R. Luskin, MD, Campbell L. Stewart, MD, Jennifer JD Morrissette, PhD, David Lieberman, MS, CGC, David J. Margolis, MD, Alexander E. Perl, MD, Misha A. Rosenbach, MD
Journal: Blood
Blood (2014) 124 (21): 2341.
https://doi.org/10.1182/blood.V124.21.2341.2341
Published: 2014
Journal Articles

Next Generation Mutational Profiling Improves Prognostication in Younger Patients with Acute Myeloid Leukemia

Caroline E Sloan, BA, Phyllis A. Gimotty, PhD, Anne Boccuti, MS, Alison R. Sehgal, MD, Jianhua Zhao, PhD, Robert Daber, PhD, Jennifer JD Morrissette, PhD, Selina M. Luger, MD, Adam Bagg, MD, Martin P. Carroll, MD
Journal: Blood
Blood (2014) 124 (21): 1032.
https://doi.org/10.1182/blood.V124.21.1032.1032
Published: 2014
Journal Articles

“Double-Hit” Cytogenetic Status Is Not Predicted By Baseline Clinicopathologic Characteristics and Is Highly Associated With Overall Survival In B Cell Lymphoma Patients

Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Jennifer JD Morrissette, PhD, Stephen J. Schuster, MD
Journal: Blood
Blood (2013) 122 (21): 4338.
https://doi.org/10.1182/blood.V122.21.4338.4338
Published: 2013
Journal Articles

Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study

Heesun J. Rogers, MD, PhD, James W. Vardiman, MD, John Anastasi, MD, Gordana Raca, MD, PhD, Natasha M Savage, MD, Athena M Cherry, Ph.D., Daniel Arber, MD, Erika Moore, MD, Jennifer JD Morrissette, PhD, Adam Bagg, MD, Yen-Chun Liu, MD, PHD, Susan Mathew, PhD, Attilio Orazi, MD, Pei Lin, MD, Sa A. Wang, MD, Carlos E. Bueso-Ramos, MD, PhD, Kathryn Foucar, MD, Robert P Hasserjian, MD, Eric D. Hsi, MD
Journal: Blood
Blood (2012) 120 (21): 3847.
https://doi.org/10.1182/blood.V120.21.3847.3847
Published: 2012
Journal Articles

Diverse Histopathologic and Molecular Responses of Acute Myeloid Leukemia to the FLT3 Inhibitor Quizartinib (AC220)

Grant E Nybakken, MD, PhD, Christopher Watt, MD, PhD, Jennifer JD Morrissette, PhD, Adam Bagg, MD, Martin Carroll, MD, Alexander E Perl, MD
Journal: Blood
Blood (2012) 120 (21): 885.
https://doi.org/10.1182/blood.V120.21.885.885
Published: 2012